American Society for Pharmacology and Experimental Therapeutics

American Society for Pharmacology and Experimental Therapeutics
Name	American Society for Pharmacology and Experimental Therapeutics
Abbreviation	ASPET
Formation	1908
Type	Learned society
Headquarters	Rockville, Maryland
Region served	United States
Membership	Scientists, clinicians, educators
Leader title	President

Contents

American Society for Pharmacology and Experimental Therapeutics is a professional society dedicated to the advancement of pharmacology and biomedical research through research dissemination, education, and advocacy. Founded alongside developments in physiology and medicine in the early 20th century, the organization connects investigators from academic institutions, pharmaceutical companies, and governmental agencies. Its activities intersect with major institutions and events including National Institutes of Health, Food and Drug Administration, Harvard University, Johns Hopkins University, and international meetings such as the International Union of Basic and Clinical Pharmacology.

History

The society traces origins to the era of early 20th-century scientific societies associated with figures such as Oswald Avery, Paul Ehrlich, and institutions like Rockefeller University and University of Cambridge. Throughout the 20th century ASPET engaged with landmark developments involving Alexander Fleming, Selman Waksman, Arthur Kornberg, and regulatory milestones tied to the Pure Food and Drug Act and activities of the Food and Drug Administration. Postwar expansion paralleled work at Massachusetts Institute of Technology, Stanford University School of Medicine, Yale University, and collaborations with the National Cancer Institute and Centers for Disease Control and Prevention. The society adapted to biotechnology revolutions led by entities such as Genentech, Amgen, and academic centers like University of California, San Francisco and Salk Institute.

ASPET's mission emphasizes support for investigators across stages of careers affiliated with centers like Columbia University, University of Pennsylvania, and Washington University in St. Louis. Objectives include promoting basic and translational research alongside clinical efforts at places such as Mayo Clinic and Cleveland Clinic, fostering communication similar to fora held by the American Association for the Advancement of Science and the Royal Society, and influencing policy dialogues involving U.S. Congress committees, the World Health Organization, and agencies analogous to the European Medicines Agency.

Membership comprises researchers from universities such as University of Chicago, industry scientists from firms like Pfizer and Merck & Co., and regulators from National Institutes of Health divisions. Governance is overseen by an elected board comparable to boards at American Chemical Society and Society for Neuroscience, with officers drawn from institutions including Duke University School of Medicine and University of Michigan. Committees mirror structures used by National Academies of Sciences, Engineering, and Medicine and partner with organizations such as American Physiological Society and Biophysical Society.

ASPET organizes annual meetings and symposia that attract presenters affiliated with Brown University, Cornell University, Princeton University, and industry laboratories like Novartis and GlaxoSmithKline. Conferences feature sessions on drug discovery topics advanced at Cold Spring Harbor Laboratory, translational research exemplified by projects at Scripps Research, and methods workshops similar to those at Federation of American Societies for Experimental Biology. International collaborations have included joint programs with European Federation for Pharmacology Societies and participation in events hosted by World Congress of Pharmacology.

The society publishes peer-reviewed journals edited by scholars from institutions such as University of California, Berkeley, University of Texas Southwestern Medical Center, and Imperial College London. Titles serve communities working on molecular signaling studied at Max Planck Institutes and clinical pharmacology nurtured at King's College London. Journals disseminate work cited alongside articles from Nature, Science, Cell, and specialized outlets like Journal of Clinical Investigation and Proceedings of the National Academy of Sciences. Editorial boards often include researchers connected to Wellcome Trust–funded projects and centers like Dana-Farber Cancer Institute.

The society confers honors that parallel recognitions from Lasker Foundation, Nobel Prize, and discipline-specific awards at Gairdner Foundation. Recipients frequently hail from laboratories led by figures associated with Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Salk Institute, Rockefeller University, and universities including University of Oxford and University of Cambridge. Awards have acknowledged contributions to pharmacology intersecting with advances in molecular biology, neuroscience, and oncology led by laureates associated with Nobel Committee–recognized work.

Educational initiatives engage trainees at institutions like Stanford University School of Medicine, MIT, and University of California, San Diego through workshops, mentorship programs, and curricula development linked to programs at National Institutes of Health training grants and fellowship schemes akin to those from Howard Hughes Medical Institute. Advocacy efforts interface with policy entities such as U.S. Congress, regulatory offices like Food and Drug Administration, and international bodies including World Health Organization to influence research funding, reproducibility standards, and clinical translation priorities. Collaborative training involves partnerships with societies like Society for Neuroscience, American Association for Cancer Research, and American Society for Clinical Oncology.

Category:Scientific societies based in the United States Category:Pharmacology organizations